Ballad Health reports positive results in financial performance, community investment, and quality for the third quarter of this fiscal year.
The health system says operating cash flow and total cash flow increased by 18.7% and 9.3% compared to the same quarter last year. Operating cash flow rose to $55.5 million from $46.7 million and total cash flow increased to $44.1 million from $40.3 million.
Ballad also reports improvements in several key quality benchmarks, including:
- Pressure ulcer rates have declined by as much as 17%
- Iatrogenic pneumothorax rate has declined by as much as 58%
- Central venous catheter-related blood stream infection rate has declined as much as 40%
- Perioperative hemorrhage or hematoma rate has declined by as much as 65%
- Postoperative respiratory failure rate has declined as much as 44%
- Clostridium Difficile rate has declined by as much as 41%
- Postoperative sepsis rate has declined by as much as 70%
- Inpatient opioid administration rate has declined by as much as 36%
- Median time from ED arrival to departure has improved by as much as 13%
- Median time from ED arrival to transport for admitted patients improved by as much as 30%
- Patients who reported their nurses “always” communicated well improved by as much as 8%
The health system says it expects to spend more than $172 million on capital improvements in the fiscal year ending in June.
You can view the full report by clicking here.